Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | SHBG | P04278 | 1/20 | 0.33 |
| ▸ | ADH1A | P07327 | 2/20 | 0.32 |
| ▸ | ADH1C | P00326 | 1/20 | 0.32 |
| ▸ | NAAA | Q02083 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7535948 | 1.00 | CYP1A2 (0.37) | CYP1A2SHBGADH1AADH1CNAAA | |
| Ammonia Solution, Strong SCHEMBL4079351 | 0.97 | CYP1A2 (0.36) | CYP1A2SHBGADH1AADH1C | |
| SCHEMBL1323167 | 0.97 | CYP1A2 (0.33) | CYP1A2CA1CA2CA4 | |
| SCHEMBL27824835 | 0.91 | CYP1A2 (0.32) | CYP1A2 | |
| SCHEMBL28901892 | 0.91 | CYP1A2 (0.32) | CYP1A2 | |
| SCHEMBL9017493 | 0.85 | CYP1A2 (0.44) | CYP1A2NAAA | |
| SCHEMBL301126 | 0.85 | CYP1A2 (0.44) | CYP1A2NAAA | |
| SCHEMBL1323223 | 0.83 | CYP1A2 (0.43) | CYP1A2NAAA | |
| SCHEMBL10597326 | 0.83 | CYP1A2 (0.43) | CYP1A2NAAA | |
| SCHEMBL17529697 | 0.83 | CYP1A2 (0.43) | CYP1A2NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113754597-B | Benzhydryl piperazine compound containing linear olefin and preparation method thereof | 凯美克(上海)医药科技有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-118344244-A | Preparation method of deuterated compound based on alkyl alcohol | 大连理工大学 | 2024-07-16 | — | — | CN | claimed |
| CN-111417627-B | Hydrogenation of Imines Using RU Complexes | 弗门尼舍有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-118026930-A | Isoquinoline derivative and synthesis method thereof | 湖南师范大学 | 2024-05-14 | — | — | CN | claimed |
| CN-113402375-B | Formation of alpha, beta-unsaturated carboxylic acids and salts thereof from metal lactones and anionic polyelectrolytes | 切弗朗菲利浦化学公司 | 2024-04-02 | — | — | CN | claimed |
| CN-117567514-A | Method for preparing spiro phosphine ligand | 凯特立斯（深圳）科技有限公司 | 2024-02-20 | — | — | CN | claimed |
| CN-116724021-A | Synthesis of polyfluorinated aryl and heteroaryl carboxamides | 巴斯夫欧洲公司 | 2023-09-08 | — | — | CN | claimed |
| CN-116535388-A | Preparation method of chlorantraniliprole | 江苏七洲绿色科技研究院有限公司 | 2023-08-04 | — | — | CN | claimed |
| CN-113224313-B | Metal organic phosphine frame glass modified metal negative current collector and preparation method thereof | 北京化工大学 | 2022-12-27 | — | — | CN | claimed |
| CN-115315419-A | Preparation of aromatic carboxamides by palladium-catalyzed carbonylation | 巴斯夫欧洲公司 | 2022-11-08 | — | — | CN | claimed |
| CN-101443416-A | Curable silicone resin composition and cured body thereof | DOW CORNING TORAY CO LTD (JP) | 2009-05-27 | — | — | CN | claimed |
| EP-2024439-A1 | CURABLE SILICONE RESIN COMPOSITION AND CURED BODY THEREOF | Dow Corning Toray Co., Ltd. (JP) | 2009-02-18 | — | — | EP | claimed |
| WO-2007132932-A1 | CURABLE SILICONE RESIN COMPOSITION AND CURED BODY THEREOF | DOW CORNING TORAY CO., LTD. (JP) | 2007-11-22 | — | — | WO | claimed |
| EP-1678132-A1 | PROCESS FOR THE PRODUCTION OF LACTAMS | Davy Process Technology Limited (GB) | 2006-07-12 | — | — | EP | claimed |
| US-7067654-B2 | Preparation of polyisocyanates containing uretdione groups | BAYER MATERIALSCIENCE AG (DE) | 2006-06-27 | — | — | US | claimed |
| WO-2005051907-A1 | PROCESS FOR THE PRODUCTION OF LACTAMS | DAVY PROCESS TECHNOLOGY LIMITED (GB) | 2005-06-09 | — | — | WO | claimed |
| US-20040110915-A1 | for production of polyurethanes via catalytic polymerization with trimethylphosphine; improved storage stability | BAYER AKTIENGESELLSCHAFT (DE) | 2004-06-10 | — | — | US | claimed |
| CN-1502605-A | Prepartion of polyisocyanates containing uretdione groups | — | 2004-06-09 | — | — | CN | claimed |
| US-20040106789-A1 | Preparation of polyisocyanates containing uretdione groups | COVESTRO DEUTSCHLAND AG (DE) | 2004-06-03 | — | — | US | claimed |
| CN-1030708-A | Catalyst composition | SHELL INT RESEARCH (NL) | 1989-02-01 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106789-A1 | Preparation of polyisocyanates containing uretdione groups | UROD, PUF60, UTS2R | CYP1A2 905/4885SHBG 512/4885ADH1A 1899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.